National Theatre of Scotland and NHS Lothian Charity: Tonic Arts present
Trolleydarity
Scratch n Sniff Staycation for the Discerning Static Traveller
At Western General Hospital, Edinburgh; St John’s Hospital, Livingston; and East Lothian Community Hospital, Haddington
December 2025 to March 2026
Co-curated by Alan Grieve and Shona Reppe
Designer – Danny Krass
Facilitators for St John’s Hospital and East Lothian Community Hospital – Minnie Crook and Dan Brown
Supported by: The Weir Charitable Trust and The William Grant Foundation
Trolleydarity lead artists Shona Reppe (lilac top) and Alan Grieve (Green Top) engage with staff and patients at the Western General Hospital in Edinburgh. Photography by Peter Dibdin
Trolleydarity’s Scratch n Sniff Staycation for the Discerning Static Travelleris an innovative new project by artists Shona Reppe and Alan Grieve co-curated for patients and staff across NHS Lothian presented by National Theatre of Scotland andNHS Lothian Charity: Tonic Arts.
Shona and Alan will present Scratch n Sniff Staycation for the Discerning Static Traveller across Western General Hospital wards with Minnie Crook and Dan Brown facilitating the Staycation in St John’s Hospital, Livingston and East Lothian Community Hospital, Haddington, from December 2025 to March 2026.
Scratch n Sniff Staycation for the Discerning Static Traveller is a series of artistic one-to -one encounters with hospital patients, visitors and staff presented by Shona and Alan (Trolleydarity.) These unique and surprising interventions will offer discerning travellers an opportunity to explore the world in a way that feels both real and magical, through the power of sound and scent. Participants will be transported on a journey without having to catch a plane or even leave their beds.
Shona Reppe and Alan Grieve’s Trolleydarity’s “immersive sensory micro adventure” will be brought to hospital bedsides, wards and waiting areas by trolley; all that will be required to explore the world is a pair of headphones and a complimentary postcard.
This brand new project transforms the everyday into the extraordinary, from the scent of a luxurious spa to the sound of crisp snow underfoot, all brought to life through the magic of sound and smell. Participants are invited to stay where they are, close their eyes, scratch, sniff and go!
This project is part of an ongoing partnership between National Theatre of Scotland and NHS Lothian Charity: Tonic Arts, the Charity’s arts in health programme which improves and supports the health and wellbeing of NHS Lothian patients and staff.
It follows on from an existing collaboration on the hosting of Portraits of an LGBTI+ Generation exhibition, at the Charity’s Tonic Galleries in both St John’s Hospital Livingston and the Western General Hospital.
Trolleydarity lead artists Shona Reppe (lilac top) and Alan Grieve (Green Top) engage with staff and patients at the Western General Hospital in Edinburgh. Photography by Peter Dibdin
Len McCaffer, NHS Lothian Charity’s Tonic Arts Manager: “We are thrilled to be partnering with the National Theatre of Scotland to bring these magical sensory adventures to patients in hospital – for the patients themselves, it gives them a gentle escape during their hospital stay and for staff, it provides a joyful shared moment to brighten a long shift.
“”Trolleydarity reminds us that care is more than clinical — it’s sensory, human and about making connections. And this is exactly what our Tonic Arts programme is all about.”
Aldi has helped Teenage Cancer Trust patients and staff in Edinburgh get into the Halloween spirit by donating a range of seasonal goodies.
The wards at Western General Hospital and the Royal Hospital for Sick Children received everything from pumpkins and decorations to costumes and treats, helping young people to celebrate Halloween away from home.
Since first partnering with Teenage Cancer Trust in 2017, Aldi has raised more than £12 million for the charity, with a commitment to raise £20 million by 2031 to ensure no young person faces cancer alone.
This Halloween, 28 Teenage Cancer Trust units across the country received donations from the supermarket, giving patients, family and staff the chance to enjoy seasonal celebrations together.
Michelle Aucott, Senior Partnerships Manager at Teenage Cancer Trust, said: “We’re so grateful to Aldi for their continued support.
“These small seasonal gestures make a big difference, helping young people to celebrate Halloween away from home.”
Liz Fox, National Sustainability Director at Aldi UK, added:“We’re proud to support Teenage Cancer Trust through a wide range of fundraising events and donations.Halloween is meant to be a time of fun and thrills, so we hope that our donation will help to bring some spooky fun and joy to young people and staff this year.”
Teenage Cancer Trust works in partnership with the NHS to provide highly-trained expert staff and specialist cancer units in NHS hospitals across the UK. The charity is there at every stage from diagnosis, through treatment and after treatment.
It also brings young people with cancer together so they can support each other.
Healthcare professionals, support staff, and teams at the Western General Hospital who have made an exceptional impact were recognised at NHS Lothian’s annual Celebrating Success Awards.
Lucy Lockhart, Clinical Support Worker at the Western General Hospital scooped the Young Achiever Award.
She joined the surgical High Dependency Unit as an apprentice aged 16 years old. Patients love her warmth, and her colleagues say she’s an absolute joy to work with. Lucy’s nominators said: “She never fails to make us smile with her kind, compassionate and polite nature.”
The Uro-Oncology Prostate Postal Service team at the hospital took home the Best Example of Quality, Innovation and Productivity Award.
Serving over 2,000 patients, the team have streamlined vital blood test monitoring for cancer patients. Their energy, enthusiasm and willingness to embrace new ideas have helped to save time, money, and improve patient care.
The Caring Champion of the Year Award went to Alison Rogers, Macmillan Cancer Support Centre Lead at the Edinburgh Cancer Centre.
She works tirelessly to support patients, staff or anyone who needs a kind word or a calming presence. From making the centre feel like a cosy haven to sprucing up the garden, she goes above and beyond every single day. Her nominator said Alison doesn’t just support people—she becomes a true friend.
Kelly Moffat, Lead Nurse – Acute Palliative Care for Lothian was awarded for her Leadership Excellence.
Described by her nominator as a true inspiration, Kelly is commended for raising the profile of palliative care across Lothian and uniting teams across the Western General, the Royal Infirmary, and St John’s Hospital.
Her nominator said: “Kelly is professional in all aspects of her work always encompassing the core values of NHS Lothian and delivering outstanding patient centred care.”
Professor John Connaghan CBE, Chair of NHS Lothian Board, said: “It’s always inspiring to hear the incredible stories of care happening every day across Lothian. These awards give us a chance to pause and celebrate the amazing work being done, and it was fantastic to do that in person again this year.
“Our finalists were nominated by colleagues and members of the public for the vital roles they play. They should feel incredibly proud of their achievements for being chosen out of hundreds of entries.”
Caroline Hiscox, Chief Executive, NHS Lothian, added: “It’s a real privilege to celebrate the incredible work of our colleagues across NHS Lothian. Many feel they’re simply doing their job and don’t seek recognition, but that’s exactly why Celebrating Success is so important.
“These awards allow us to shine a light on those who go above and beyond, and who truly embody NHS Lothian’s values. I want to thank all our finalists for their resilience, professionalism, and hard work, and offer my warmest congratulations on their well-deserved achievements.”
“Thank you to everyone who took the time to submit a nomination. It demonstrates great leadership to recognise and celebrate the contributions of colleagues.”
Proudly sponsored by NHS Lothian Charity, the awards shine a spotlight on the outstanding contributions of individuals and teams working tirelessly to improve care and support across the region.
PROJECT TO INVESTIGATE LONG-STANDINGCANCER MYSTERY
Scientists are seeking participants in Edinburgh and the Lothians to help solve one of the longest standing mysteries in cancer – how and why it can take decades for mesothelioma to develop after exposure to asbestos.
The Cancer Research UK-funded project, Meso-ORIGINS led by Professor Kevin Blyth at the University of Glasgow, aims to find a way to detect and treat mesothelioma earlier and investigate if the disease can be prevented in the first place.
Mesothelioma is a cancer which develops in the pleural space, the lining of the lung, and is caused by exposure to asbestos. Only a small proportion of patients with inflammation of the pleural space go on to develop mesothelioma. Asbestos fibres can embed themselves in different parts of the lungs so the disease can develop at different rates in different parts of the pleural space.
Only around 4 in 10 (44.3%) people diagnosed with mesothelioma in Scotland survive their disease for one year or more making new ways to detect it and treat it earlier vital.*
The research team are keen to recruit people in Edinburgh and the Lothians already diagnosed with benign (non-cancerous) inflammation in the lungs, who may have been exposed to asbestos.
The Western General in Edinburgh is among 28 hospitals across the UK currently recruiting patients, with the project extending over the next two years. Eligible patients who attend these hospitals will be offered the chance to take part in the study and contribute to mesothelioma research.
Vital data and tissue samples from participants will help build a picture of who is at most risk of developing mesothelioma and identify any genetic differences or biological markers which indicate a predisposition to the disease.
Dr Alexandrea MacPherson, Meso-ORIGINS Project Manager at the University of Glasgow, said:“Mesothelioma is a disease of time and space – after initial exposure to asbestos it can evolve over decades at different times and different places within the pleural space.
“We want to understand why mesothelioma takes so long to develop and to discover new ways of predicting the disease so it can be caught early.
“Once diagnosed there are very few effective treatments so discovering the signs before it begins, and finding a way to prevent it developing, is key.”
Mesothelioma currently has a very poor survival rate and can take more than 40 years to develop. Early symptoms such as chest pain, fatigue and constant coughing can be overlooked because they resemble other illnesses.
According to Cancer Research UK, the UK currently endures the highest incidence of mesothelioma worldwide, with the disease more prevalent in men due to occupation-related exposure, and around 200 new cases in Scotland each year.**
There was widespread industrial use of asbestos between 1950 and 1980, particularly in Glasgow and surrounding areas as the material was manufactured in nearby towns such as Clydebank and used in heavy industry like ship building, which the River Clyde was famed for.
Research funded by Cancer Research UK revealed there are no safe levels of working with asbestos. This led to health and safety policies to protect future generations from mesothelioma and the charity continues to invest in finding new ways to beat the devastating disease.
While asbestos has been illegal to use in the UK since the early 1990s, mesothelioma cases have increased in recent years due to the long period of time it can take to develop, and asbestos remains legal in other countries.
Dr Catherine Elliott, Cancer Research UK Director of Research, said:“Mesothelioma, despite asbestos being outlawed decades ago, is increasingly being diagnosed and is in desperate need of more effective treatments.
“Cancer Research UK is delighted to support this research project which aims to shed a light on why it can take years to develop after someone is exposed to asbestos.
“Long-term in-depth research projects like this are essential to developing our understanding of cancer and helping us find ways to stop it in its tracks.”
A groundbreaking new imaging approach developed by researchers at Heriot-Watt University has shown ‘extremely encouraging’ results in early-stage clinical trials on prostate cancer at the Western General Hospital in Edinburgh.
The ongoing clinical trial demonstrated an initial 94% sensitivity rate in tumour detection. The new test is delivered in less than 20 minutes and relies on existing clinical ultrasound equipment.
The cost of an ultrasound scanner is a fraction of an MRI scanner (around 10%), so the new approach provides clinicians with a valuable new tool to help better guide prostate biopsies and focal therapy, a technique that destroys cancer cells.
All men are at risk of prostate cancer with 1 in 8 diagnosed with the disease in their lifetime. 52,000 men in the UK are diagnosed with prostate cancer every year – 144 every day.
Currently, a relatively unreliable blood test, called a Prostate Specific Antigen or PSA test, means many men are unnecessarily sent for an expensive MRI scan in an attempt to spot cancerous tissue. Current long waiting lists for tests mean treatment can be delayed.
Despite using multi-parametric MRI (mpMRI – a specialist type of scan) for prostate cancer diagnosis, up to 28% of clinically significant tumours are missed and 1 in every 2 individuals with positive MRI findings receive a negative biopsy result.
Less Grey Imaging Ltd is a spin-out from Heriot-Watt University, Edinburgh, with the mission to bring greater clarity to prostate imaging. The technology offers clinicians up to a 20-fold increase in resolution compared to mpMRI, which provides a grey and difficult-to-read image.
The new imaging test begins by injecting a commonly used contrast agent into a vein that contains millions of tiny and harmless microbubbles that travel through the patient’s bloodstream to the prostate.
The team uses a technique known as super resolution ultrasound imaging (SRUI) to track these microbubbles as they flow inside the prostate. Due to the altered blood flow in cancerous tissue, the image highlights previously unseen tumours, enabling earlier diagnosis.
Dr. George Papageorgiou, CEO of Less Grey Imaging, explains how the new technique aligns well with histopathology, the diagnosis and study of diseases of the tissues which involves examining tissues or cells under a microscope. He said: “Our initial clinical findings in prostate imaging align well with histopathology, highlighting its potential to reliably detect clinically significant prostate cancer.
“Currently, prostate cancer diagnosis varies widely across the country, with many patients being diagnosed too late for curative treatment. By integrating ultrasound more prominently into the diagnostic pathway, we can ensure equal opportunities for early diagnosis across all regions of the UK.
“Less Grey Imaging’s mission is to revolutionise prostate imaging by delivering clarity and precision. Urologists will have an imaging tool that enables accurate diagnoses and quicker decision-making. Our software deploys existing ultrasound equipment to enhance image quality down to microscopic detail. By minimising reliance on radiologist assessment, we intend to streamline workflows, reduce NHS costs, and improve patient efficiency.”
The potential of the technology has been recognised by Innovate UK, which awarded the company a £370,000 grant through its ICURe Exploit Funding programme. This is being used to support the company’s product development and attract further investment.
The UK has a higher cancer mortality rate compared to several other developed countries, and more recently, the Darzi report, a bleak review of the NHS published in September 2024, revealed that waiting times targets for the first treatment for cancer have not been met since December 2015.
Professor Vassilis Sboros from Heriot-Watt University and co-founder of Less Grey Imaging, explained how the technique can help support an NHS that is fit for the future. He said:“Our super-resolution ultrasound imaging technology provides a leap in imaging resolution.
“By utilising existing ultrasound scanners found in hospitals and clinics worldwide, we’re able to produce high-resolution images of the prostate that clinicians have never seen before. This is exactly what the new Government needs to tackle the challenges facing the NHS.
“Back in 2019, we proved the concept worked in our lab but now we have shown it works during our initial patient trials. It’s just like looking inside the body with a microscope, allowing clinicians to see 20 times more detail than before. Even concealed tumours are possible to identify.
“With one man dying from prostate cancer every 45 minutes in the UK, we hope earlier detection will radically improve treatment outcomes, saving lives while reducing the number of people sent for unnecessary and often risky tests.”
Professor Alan McNeill is a Consultant Urological Surgeon at the Western General Hospital, Edinburgh and founder trustee of charity Prostate Scotland. He said: “The initial trial results are extremely encouraging, providing really useful information for the diagnosis and treatment of prostate cancer. This is the most common cancer in men but, if it is caught early while the cancer remains within the prostate, it can be cured in the majority of cases.
“The technology has the potential to significantly enhance diagnostic accuracy, help clinicians like me to carry out more targeted biopsies and even focus treatments with greater precision.
“I can anticipate it benefiting treatments like focal therapy by allowing us to pinpoint and treat cancerous tissue with greater accuracy. Nearly every week, my colleagues and I meet men in their 50s or early 60s suffering from advanced prostate cancer that leaves them with fewer treatment options. We continue to raise awareness and encourage earlier diagnosis for all men.”
Gary Tait was treated for prostate cancer five years ago after his wife, a practice nurse, encouraged him to see his GP. He is now Chair of Edinburgh & Lothian Prostate Cancer Support Group. He said: “Being diagnosed and treated for prostate cancer is an incredibly anxious time so it is very positive to see these trial results which indicate that the new ultrasound technique could lead to more accurate diagnosis of prostate cancer.
“From the perspective of men who are unaware of a developing tumour in their prostate, this improved method of diagnosis could lead to earlier treatment which improves the likelihood of a good outcome.
“We fully support the development of this new technology which raises the possibility of enabling more men to be both diagnosed and treated earlier than they can be at present.”
Professor Gill Murray, deputy principal of business and enterprise at Heriot-Watt University, said: “This breakthrough exemplifies Heriot-Watt’s commitment to transforming innovative research into real-world healthcare solutions with global applications.
“Less Grey Imaging represents exactly the kind of high-impact spinout company we aim to nurture – one that combines cutting-edge science with clear commercial potential and significant societal benefit.
“These early clinical trials are particularly encouraging as they demonstrate how our research excellence can help address critical healthcare challenges while creating economic opportunities.
“By developing technology that makes cancer diagnosis more accessible and accurate, we’re supporting the NHS and positioning Scotland as a leader in medical innovation.
“Addressing global challenges through the real world application of our research is why we established our Global Research Institutes. Each institute has its own distinctive DNA, and our global research institute in health and care technologies excels in the creation and growth of new innovative businesses.
“Less Grey is a fantastic example of one of these businesses and perfectly aligns with our enterprise strategy of fostering research-led companies that can scale globally while delivering tangible benefits to patients and healthcare systems worldwide.”
Fighting cancer is one of the five key themes for Health and Care Technologies. Anyone interested in collaborating with the new Health and Care Technologies global research institute at Heriot-Watt University can contact GRID@hw.ac.uk.
Funding for projects to benefit patients and clinical staff
A total of £1.5 million funding in 2024-25 is supporting 12 projects to continue providing direct and personalised support to patients with cancer.
The Single Point of Contact (SPoC) pilots provide patients with ongoing contact to support them, putting them at the heart of all decisions and actions involving them throughout their care journey.
The NHS Lothian SPoC uses a centralised digital hub delivering telephone communication and support to patients with a range of cancer types.
Around 40% of calls are diverted away from Clinical Nurse Specialist workload, which has led to improvements in the quality of their telephone contacts. Patient engagement work carried out by NHS Lothian and Healthcare Improvement Scotland has indicated high satisfaction with the service.
Confirming the funding, which is included in the 2024-25 Budget, as he met nurses at Edinburgh Cancer Centre with experience of the service, First Minister John Swinney said: “We are fully focused on improving cancer survival, and delivering excellent and accessible care is at the core of how we do that.
“The Single Point of Contact Service meets requirements identified by Boards to deliver improvements in communication and support for patients with navigating cancer care.
“By taking in the region of 2,000 calls per month and providing person-centred support to those patients throughout their care journey, the Edinburgh Single Point of Contact project provides consistent access for patients to have conversations about their care, freeing up capacity for specialist staff to focus on the most complex cases.”
Katie Gibson, Neuroendocrine Tumour Clinical Nurse Specialist at the Edinburgh Cancer Centre, said: “I’ve seen first-hand how the SPoC service has transformed our ability to care for cancer patients.
“The centralised system streamlines communication and allows us to spend more quality time with those who need it most.
“As a result, patients are aware of who to contact for the support and advice they require from diagnosis , treatment and beyond.”
Over £1.5 million will support 12 pilot projects across Scotland to deliver a single point of contact to people diagnosed with cancer.
Funding has been delivered in response to needs identified by individual Boards and proposals submitted by them, pilots vary by cancer type and location:
NHS Lothian has received £ 343,740 to support the telephone-based SPoC service at Edinburgh Western General, serving boards within the South East Scotland Cancer Network
NHS Borders has received £82,000 for 3 cancer care co-ordinators, providing support across a variety of cancer sites
NHS Dumfries and Galloway has received £71,000 for 2 cancer co-ordinator posts, providing a telephone-based support service across a range of tumour sites
NHS Fife has received £107,354 to staff a Single Point of Contact Hub, dealing with all urgent suspected cancer referrals.
NHS Forth Valley has received £67,556 for 2 healthcare support workers (HCSW) providing a single point of contact for 7 tumour groups
NHS Ayrshire and Arran, NHS Forth Valley, NHS Greater Glasgow and Clyde, and NHS Lanarkshire have received total funding of £202,668to develop a regional approach to digital remote follow up of prostate cancer patients in the West of Scotland
NHS Greater Glasgow and Clyde has received £67,566 for 2 support workers to augment specialist gynaecological nursing support and £141,324 for 4 SPoC roles across GGC sites to smooth and facilitate the patient journey, for people diagnosed with lung cancer
NHS Grampian has received £84,500 for 3 posts to provide a joint service with Macmillan Navigators, providing support following an Urgent Suspicion of Cancer (USC) referral
NHS Highland has received £270,680 for 7 Cancer Support Workers providing tailored support throughout diagnostic pathway and onto treatment
NHS Tayside has received £33,288 to provide support for people diagnosed with advanced Upper Gastrointestinal or Hepatopancreatobiliary tumours and lung, renal and prostate cancers
NHS Western Isles has received £68,000 for 2 HCSWs, as part of the Macmillan Team, to support people with all types of cancer
Health Improvement Scotland is currently carrying out a scalability assessment of all 12 projects in order to identify best practice and how best to scale and expand these pilots.
Two units which provide vital care and treatment to some of the most unwell patients in Scotland have been transformed by NHS Lothian as part of a multi-million pound investment.
A new Cancer Assessment Unit (CAU) and an oncology ward for systemic anti-cancer treatment (SACT) are now open and delivering care to patients at the Edinburgh Cancer Centre (ECC).
The ECC, based in the Western General Hospital, supports an average of 7,000 inpatient admissions, 25,000 day-cases and 100,000 outpatient attendances each year from across the Lothians, Scottish Borders, Fife and Dumfries and Galloway.
The demand for treatment and services has significantly outgrown facilities and available space in recent times, but the new refurbishments have enabled significant modernisation to improve the care and overall experience for patients.
Chris Stirling, Site Director for the Western General Hospital, NHS Lothian, said: “This is a great step forward to upgrade our existing infrastructure.
“We know how important and reassuring a welcoming environment is at a worrying time, and we’re delighted that our current patients have access to better facilities.
“This is an important step in our ambition toward a new centre for the future of the southeast of Scotland to enable us to meet the rising demand of a growing population.”
The upgrades are part of a £24 million package of enabling works within oncology services, funded by the Scottish Government, which are due to be completed in 2024.
This is in advance of a longer-term plan for the full reprovision of the Edinburgh Cancer Centre which has been proposed by NHS Lothian in response to the population growth in the region and constraints of the existing ECC.
The refurbished SACT ward, which is where treatments like chemotherapy and immunotherapy are administered to patients, has seen an extensive programme of work – including new flooring, ceilings, paintwork, lighting, bed head services, fire safety upgrades and a new reception area.
There is now a dedicated space for patients to be assessed and prepped for their therapy, and comfortable chairs for patients to begin their treatment while awaiting a bed.
Four-bedded bays have been reconfigured into two-bedded bays, giving patients greater privacy. Where eight patients previously shared a bathroom, there is now an ensuite facility for every two beds.
The new CAU provides a fresh, purpose-built environment for patients to attend for assessment or diagnostic tests prior to potential admission to an inpatient hospital bed.
The CAU also has a dedicated family room with a double sofa bed and its own ensuite facility for relatives who may need to stay close to their loved one overnight.
Mrs McLean, 61 from Edinburgh, said: “Following a sudden and unexpected reaction to my treatment, I was taken to the new Cancer Assessment Unit. I was so grateful to be welcomed immediately by the medical team there.
“At such a worrying time for me, the nurses and doctor were not only reassuring, friendly and kind, but their professional clinical care was exceptional. Their thoughtfulness extended to my family sitting in the waiting area close to my treatment bay who were soon invited to join me.
“I really appreciated being in such a modern, comfortable facility and my experience of the CAU could not have been better or more positive. I can’t thank the medical staff enough for their excellent care of me in the new unit.”
A team at the Western General Hospital is significantly reducing operating room waste and saving money after introducing reusable surgical hats.
Generally, staff working in surgical theatres use hats as part of infection control measures and at the Western General alone they get through over 30,000 disposable hats a year.
The Breast Theatres team, eager to make their practices more sustainable, applied to NHS Lothian Charity to secure grant funding for washable hats.
Erica Revie, Consultant Surgeon in the Breast Theatres who led the project, said: “We had seen that there was a Climate Challenge Grant available from NHS Lothian Charity so we put together a proposal to try out reusable hats.
“We contacted NHS Fife, which is already using reusable hats, to discuss the practicalities of implementation, and contacted their supplier about our needs in order to undertake a trial. The Infection Prevention and Control Team and Laundry Service were also consulted to ensure we could still ensure the highest standard of cleanliness.”
Beyond cutting waste, the hats are also embroidered with individuals’ names and roles which has improved communication during emergencies when new staff enter the operating room.
Theatre Sister Lorraine Murray, who was also integral to the trial, was called to support a cardiac arrest not long after the introduction of the hats. A staff member who did not know her was able to ask her for specific help by name and instantly understand her role within the team.
“It’s an easy change to make with dual benefits – environmental savings and improved communication,” said Erica. “We encourage other departments and hospitals to embrace it.”
By switching to reusables, the Breast Theatre operating rooms have significantly reduced discarded hats. Once rolled out to the rest of the Western General, it will save the hospital over £6,000 as well as reducing their carbon footprint.
Although it would not be logistically possible to provide hats with names for all theatre staff across the health board, NHS Lothian are looking to roll out generic versions and an initial set of samples are on their way for feedback.
Dr Jane Hopton, Sustainability Lead for NHS Lothian, said: “This is a great example of another team in Lothian wanting to make a difference in their area.
“They applied for the Climate Challenge Grant and used that funding to drastically reduce the waste caused by disposable surgical hats. Well done to Erica, Lorraine and everyone else involved in making this happen.
“Providing reusable surgical hats across all theatres in NHS Lothian is an important next step in reducing waste and our environmental impact.”
Jane Greenacre, Head of Programmes at NHS Lothian Charity, said: “The Charity is delighted to be able to support staff across NHS Lothian to take forward innovative projects like this.
“The aim of our Climate Challenge Grants is to enable staff to explore initiatives that help them embed green practices into day-to-day activities and reduce the impact of healthcare on the environment.”
Police Scotland is appealing for information on the whereabouts of 34-year-old Ryan Gandy who went missing from the Western General Hospital in Edinburgh yesterday at around 5pm (Wednesday, 22 November, 2023).
He was last seen at Crewe Road South.
Ryan is described as being around 6ft tall, of slim build with dark receding hair.
He was wearing a blue Nike dry-fit top, black jogging bottoms, dark-coloured trainers, and a black Hoodrich gilet.
He has a tattoo with the word “Katy” on his right arm and scars on both sides of his face.
Officers are carrying out extensive searches and reviewing CCTV in an effort to trace him.
Members of the public are advised not to approach Mr Gandy if they see him but to contact police immediately.
Anyone who knows of his present whereabouts should contact Police Scotland on 101, or in an emergency on 999. Please quote incident number 2515 of Wednesday, 22 November, 2023.
Information can also be passed via Crimestoppers on 0800 555 111 where anonymity can be maintained.
The Cancer Navigation Hub, based in Edinburgh Cancer Centre at the Western General Hospital, recently celebrated one year of the service launching.
The team helps patients and healthcare professionals to navigate cancer pathways, ensuring enquiries are directed to the appropriate care team in a timely and efficient way.
The team is made up of Cancer Pathway Coordinators and acts as a single point of contact for patients who’ve received a cancer diagnosis. Coordinators are also trained to assist healthcare professionals and helps to alleviate the pressure on clinical teams.
Katie Seville, Assistant Service Manager in Cancer Performance, said: “In just one year we’ve seen the hub make such a difference to the ease with which patients and staff can access the information and support they need.
“The team is in high demand and we’re looking to further expand and grow the service into new areas, providing more personalised and holistic support for patients throughout their diagnosis and treatment.”
The Cancer Navigation Hub initially served five tumour groups – lung, melanoma, head and neck, gynaecology, and urology. In April 2023, the hub expanded to cover the neuroendocrine tumour group followed by breast in August 2023.
During the first five months of the service (October 2022 to February 2023) the team handled on average over 1,100 calls per month, 38% of which were administrative queries or issues that could be resolved by the Cancer Pathway Coordinators.
In the month after incorporating the breast service, the team handled just over 1,900 calls across all tumour groups, with 44% of all calls being dealt with by the coordinators.
Since January 2023, the Cancer Navigation Hub has also been proactively calling newly diagnosed patients to introduce the hub and direct patients to support services.
In June 2023, during the launch of the new Cancer Strategy, the team was among those to meet Michael Matheson, Cabinet Secretary for NHS Recovery, Health and Social Care.
Congratulations to the team for a brilliant first year.
